Editorial
doi: 10.2174/156652402204220325161921.
Targeting tumor hypoxia and hypoxia-inducible factors (HIFs) for the treatment of cancer- A story of transcription factors with novel approach in molecular medicine
Affiliations
- PMID: 35603885
- DOI: 10.2174/156652402204220325161921
Item in Clipboard
Editorial
Targeting tumor hypoxia and hypoxia-inducible factors (HIFs) for the treatment of cancer- A story of transcription factors with novel approach in molecular medicine
Curr Mol Med.
2022.
No abstract available
Similar articles
-
Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells.J Cell Mol Med. 2013 Jan;17(1):30-54. doi: 10.1111/jcmm.12004. Epub 2013 Jan 10. J Cell Mol Med. 2013. PMID: 23301832 Free PMC article.
-
Progress on hypoxia-inducible factor-3: Its structure, gene regulation and biological function (Review).Mol Med Rep. 2015 Aug;12(2):2411-6. doi: 10.3892/mmr.2015.3689. Epub 2015 Apr 27. Mol Med Rep. 2015. PMID: 25936862 Review.
-
Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways.Drug Resist Updat. 2011 Jun;14(3):191-201. doi: 10.1016/j.drup.2011.03.001. Epub 2011 Apr 3. Drug Resist Updat. 2011. PMID: 21466972 Review.
-
Assessment of Stabilization and Activity of the HIFs Important for Hypoxia-Induced Signalling in Cancer Cells.Methods Mol Biol. 2019;1928:77-99. doi: 10.1007/978-1-4939-9027-6_6. Methods Mol Biol. 2019. PMID: 30725452
-
Hypoxia-inducible factors not only regulate but also are myeloid-cell treatment targets.J Leukoc Biol. 2021 Jul;110(1):61-75. doi: 10.1002/JLB.4RI0820-535R. Epub 2020 Oct 18. J Leukoc Biol. 2021. PMID: 33070368 Review.
Cited by
-
Hyperoxic-hypoxic Paradox: Breast Cancer Microenvironment and an Innovative Treatment Strategy.Anticancer Agents Med Chem. 2024;24(10):729-732. doi: 10.2174/0118715206290816240220062545. Anticancer Agents Med Chem. 2024. PMID: 38415470 Review.
-
Innovative Nanomaterials for Targeting Hypoxia to Improve Treatment for Triple-negative Breast Cancer.Recent Pat Biotechnol. 2024;18(4):269-272. doi: 10.2174/0118722083270521231027074157. Recent Pat Biotechnol. 2024. PMID: 37957916 Review.
-
Transcription factor TCF7L1 targeting HSPB6 is involved in EMT and PI3K/AKT/mTOR pathways in bladder cancer.J Biol Chem. 2025 Jan;301(1):108024. doi: 10.1016/j.jbc.2024.108024. Epub 2024 Nov 26. J Biol Chem. 2025. PMID: 39608715 Free PMC article.
-
Limning of HIF-2 and HIF-3 in the Tumor Microenvironment: Developing Concepts for the Treatment of Hypoxic Cancer.Curr Mol Med. 2025;25(5):513-521. doi: 10.2174/0115665240303179240427071748. Curr Mol Med. 2025. PMID: 38766832 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
